0 NASDAQ Companies - February 27, 2019Ocean Power Technologies Announces the Date for the Release of the Third Quarter Fiscal 2019 Results, Conference Call and WebcastRead More
0 NASDAQ Companies - February 27, 2019uniQure Presents New Preclinical Data on AMT-130 at the CHDI’s 14th Annual Huntington’s Disease Therapeutics ConferenceRead More
0 NASDAQ Companies - February 27, 2019Gevo and HCS Group Enter Into Game-Changing, Long-Term Supply Agreement for Renewable Isooctane Worth Up to $180 MillionRead More
0 NASDAQ Companies - February 27, 2019Eidos Therapeutics Initiates ATTRibute-CM, a Phase 3 Study of AG10 in ATTR-CM with Registrational 12-month EndpointRead More
0 NASDAQ Companies - February 27, 2019Idera Pharmaceuticals Completes Enrollment Into the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor TreatmentRead More
0 NASDAQ Companies - February 27, 2019ProQR Reports Fourth Quarter and Full Year 2018 Operating and Financial ResultsRead More
0 NASDAQ Companies - February 27, 2019Antares Pharma to Present at the Raymond James & Associates 40th Annual Institutional Investors ConferenceRead More
0 NASDAQ Companies - February 27, 2019G1 Therapeutics to Host Investor Day 2019 on March 6, 2019Read More
0 NASDAQ Companies - February 27, 2019KVH Industries to Host Fourth Quarter/Year-end Conference Call on March 1, 2019Read More
